Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Bronchodilator Recalled
04/03/2020
A Class II recall is active for a prescription bronchodilator used to treat asthma, emphysema, and chronic bronchitis.
A Class II recall is active for a prescription bronchodilator used to treat asthma, emphysema, and chronic bronchitis.
A Class II recall is active for...
04/03/2020
Pharmacy Learning Network
News
OTC Pain Relief Products Recalled
04/03/2020
More than a dozen lots of Advil tablets, drops, and capsules are being recalled by GlaxoSmithKline because product labeling is missing required safety warning information.
More than a dozen lots of Advil tablets, drops, and capsules are being recalled by GlaxoSmithKline because product labeling is missing required safety warning information.
More than a dozen lots of Advil...
04/03/2020
Pharmacy Learning Network

Advertisement

News
New Study Provides Additional Insight About Critical Patients Amid the COVID-19 Pandemic
04/03/2020
A new study has presented further characterization of critically ill patients with COVID-19 who obtained treatment.
A new study has presented further characterization of critically ill patients with COVID-19 who obtained treatment.
A new study has presented...
04/03/2020
Pharmacy Learning Network
News
New Study Explores the Psychological Impact of COVID-19 Among Health Care Providers
04/01/2020
“Special interventions to promote mental well-being in health care workers exposed to COVID-19 need to be immediately implemented, with women, nurses and frontline workers requiring particular attention,” researchers of a new study expressed.
“Special interventions to promote mental well-being in health care workers exposed to COVID-19 need to be immediately implemented, with women, nurses and frontline workers requiring particular attention,” researchers of a new study expressed.
“Special interventions to...
04/01/2020
Pharmacy Learning Network
News
FDA: Agency Requests the Immediate Removal of All Ranitidine Products From Market
04/01/2020
In a new press release, the FDA said it is requesting that all manufacturers withdraw prescriptions and over-the-counter ranitidine products from the market.
In a new press release, the FDA said it is requesting that all manufacturers withdraw prescriptions and over-the-counter ranitidine products from the market.
In a new press release, the FDA...
04/01/2020
Pharmacy Learning Network

Advertisement

News
Patients With Underlying CVD at Greater Risk of Mortality From COVID-19
03/31/2020
Researchers recently found that mortality rates for COVID-19 patients jump substantially when they have underlying cardiovascular disease and myocardial injury.
Researchers recently found that mortality rates for COVID-19 patients jump substantially when they have underlying cardiovascular disease and myocardial injury.
Researchers recently found that...
03/31/2020
Pharmacy Learning Network
News
Commonly Used ICU Meds Lack Information on Product Labels
03/30/2020
Researchers found that commonly used ICU injectable medications often have limited, and sometimes inadequate, information for calculating an appropriate dosage.
Researchers found that commonly used ICU injectable medications often have limited, and sometimes inadequate, information for calculating an appropriate dosage.
Researchers found that commonly...
03/30/2020
Pharmacy Learning Network
News
Stimulant Patches Recalled
03/27/2020
A Class II recall is active for a prescription stimulant used to treat attention-deficit/hyperactivity disorder.
A Class II recall is active for a prescription stimulant used to treat attention-deficit/hyperactivity disorder.
A Class II recall is active for...
03/27/2020
Pharmacy Learning Network

Advertisement

News
Hypokalemia Medication Recalled
03/27/2020
The FDA has issued a nationwide recall for a prescription drug used to treat low levels of potassium in the blood.
The FDA has issued a nationwide recall for a prescription drug used to treat low levels of potassium in the blood.
The FDA has issued a nationwide...
03/27/2020
Pharmacy Learning Network
News
Antibiotic Recalled
03/27/2020
A prescription antibiotic used to treat a variety of bacterial infections, such as acne, urinary tract infections, and respiratory infections is being recalled.
A prescription antibiotic used to treat a variety of bacterial infections, such as acne, urinary tract infections, and respiratory infections is being recalled.
A prescription antibiotic used...
03/27/2020
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023

Featuring David Rubin, MD

Featuring David Rubin, MD
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023

Featuring Paul Schulz, MD 

Featuring Paul Schulz, MD 
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023

Featuring Ronald Vender, MD, FRCPC

Featuring Ronald Vender, MD, FRCPC ...
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023

Featuring Abigail Cline, MD, PhD, FAAD

Featuring Abigail Cline, MD, PhD, FAA...
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023

Featuring Paul Schulz, MD

Featuring Paul Schulz, MD
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023

Featuring Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC

Featuring Chris Fausel, PharmD, MHA, ...
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Julie Gould
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use